Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Initiative
An initiative dedicated to studying infection-associated chronic diseases
To become a center of excellence that improves the health of patients with chronic diseases in which infection or its immune response plays a major etiologic role.
To provide leadership, facilitate multidisciplinary collaboration, make new discoveries, and educate in the field of infection-associated chronic diseases.
Our primary aim is to study the roles that infection and the immune response play in the symptoms of patients suffering from chronic, unexplained diseases.
We are now recruiting patients and healthy volunteers for our newest ME/CFS research study on the neuroendocrine system. Please note this study is only open to people residing in the San Francisco Bay Area.
Chronic fatigue syndrome may finally be taken seriously by the medical field. Many doctors viewed the syndrome as a psychological illness, but new research suggests it's resulted from infection.
Read about Jose Montoya's revelation and the hope of successful treatment in The Guardian here.
Our deepest sympathies go out to Dr. A. Martin Lerner’s family, loved ones and collaborators. His immeasurable contributions to the field of ME/CFS and his dedication to improve the lives of many patients will forever be remembered by the entire ME/CFS community. Should the need arise for patients in Dr. Lerner’s practice, we will do our best to accommodate new patients without adversely impacting those already in our care and those waiting to be seen. At Stanford and with Dr. Montoya’s leadership, we have a superb team of Physician Assistants willing to see new patients. Please contact (650) 736-5200 to coordinate your Appointment.
Dr. Montoya’s commitment to helping CFS patients was featured in the December 2015 issue of Oprah Magazine. Please click here to access the article.
At the ME/CFS Initiative, we are excited to learn that the NIH is taking steps to follow IOM and NIH P2P’s recommendations of increasing support on extramural research for ME/CFS. Using a multidisciplinary approach, we might be able to improve the understanding of this disease and develop targeted treatment. Please click here to read the official news release.
On June 18th 2015, Dr. Lily Chu, member of the Stanford ME/CFS Initiative Advisory Board and co-Vice President of the International Association for ME/CFS, will be presenting during the Solve ME/CFS Initiative (SMCI) Free Webinar Series. To learn more about speakers, dates and how to join and register, please visit http://solvecfs.org/smci-2015-webinar-series/
A Stanford Medicine video of Dr. Montoya featured this week in the Washington Post's article on the IOM Report. Watch the video at http://www.washingtonpost.com/news/to-your-health/wp/2015/02/10/chronic-fatigue-syndrome-is-a-real-condition-not-a-psychological-illness-expert-panel-says/
Dr. Montoya comments on the IOM ME/CFS report in this article
Dr. Montoya and his research was recently featured in an ABC7 News feature about ME/CFS. Check out the video on the ABC7 website.
Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. (please note this link will direct you to a webpage unaffiliated with Stanford University)
Persistent human herpesvirus-6 infection in patients with an inherited form of the virus. (please note this link will direct you to a webpage unaffiliated with Stanford University)
Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology.(please note this link will direct you to a webpage unaffiliated with Stanford University)
Response to valganciclovir in Chronic Fatigue Syndrome patients with human herpesvirus 6 and Epstein-Barr viru IgG antibdy titers. (please note this link will direct you to a webpage unaffiliated with Stanford University)
A multicenter blinded analysis indicates no association between chronic fatigue syndrome/myalgic encephalomyelitis and either xenotropic murine leukemia virus-related virus of polytropic murine leukemia virus. (please note this link will direct you to a webpage unaffiliated with Stanford University)
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study. (please note this link will direct you to a webpage unaffiliated with Stanford University)